Nancy M. Cappello on the transformative power of social media

Nancy M. Cappello, PhD, director and founder of Are You Dense and Are You Dense Advocacy, wrote a new post for The Huffington Post about the role social media has played in her own life and the role it plays in the lives of women from all over the world. She said the internet and social media have “transformed our lives,” opening “a global connection to those with similar interests and passions.”

For women affected by breast cancer, Cappello said, social media has been especially helpful in building a sense of community and easing the concerns of anyone who may feel confused, frightened or hopeless.

“Social media have brought together a community of breast health advocates, breast cancer survivors, and health care providers, to communicate about the many aspects of breast cancer such as prevention, risks, screening, treatments, and promising research for a cure,” she wrote. “Open 24 hours, within seconds of breast cancer survivors’ posts about side effects from treatment, decisions about surgery and their most intimate anxieties and fears, the cheer-leading team of survivors, caregivers, and health care providers intervene.”

Click below for the full text of Cappello’s post. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.